Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Ophthalmology stories

Oct 19, 2026

FDA approves Ryzumvi eye drops for presbyopia

The FDA has approved Ryzumvi (phentolamine 0.75%) eye drops to treat presbyopia in adults, marking a label expansion for the product marketed by Viatris.

Oct 19, 2026·3 sources
00
Sep 21, 2026

Beacon Therapeutics' gene therapy succeeds in phase 2 trial for rare inherited eye disease

Beacon Therapeutics reported its experimental gene therapy improved low-light reading ability in a late-stage trial for X-linked retinitis pigmentosa (XLRP), a rare inherited eye disease that can cause blindness. The company succeeded where larger drugmakers including Johnson & Johnson and Biogen have failed.

Sep 21, 2026·2 sources
00
Jun 24, 2026

Ollin Biosciences Raises $330 Million for Late-Stage Eye Disease Drug Trials

Texas-based biotech Ollin Biosciences secured $330 million in funding to advance late-stage clinical studies of its experimental eye disease treatment, representing one of the largest recent funding rounds in ophthalmology.

Jun 24, 2026·2 sources
00
Apr 8, 2026

Smart Contact Lens Monitors Eye Pressure and Delivers Glaucoma Drugs in Preclinical Tests

Researchers at the Terasaki Institute for Biomedical Innovation developed a smart contact lens that combines real-time intraocular pressure monitoring with responsive drug delivery for glaucoma patients, showing promise in preclinical models.

Apr 8, 2026·2 sources
00

Virus from Seafood Jumps to Humans, Causing Chronic Eye Disease

A virus that typically infects marine animals such as shrimp and fish has jumped to humans and is causing chronic eye disease in some people, according to a study published in Nature Microbiology.

Apr 8, 2026·1 source
00

Top claims

  • ▪Presbyopia is commonly managed with optical correction like reading glasses, bifocals, multifocals, contact lenses, and miotic eye drops that increase depth of focus via pupillary constriction
  • ▪The Phase III VEGA-2 clinical trial evaluated phentolamine eye drops in combination with topical pilocarpine against placebo
  • ▪Viatris markets Ryzumvi and holds exclusive U.S. commercialization rights through a licensing agreement with Opus Genetics

Topics

FDA drug approvalBiotech innovationClinical Trial Design & EvaluationClinical trialsDrug Approval and Clinical TrialsDrug Policy, Pricing & ApprovalGene therapyClinical evaluationPharmaLyme disease treatmentTexasLongevity & biohackingWearables & Health TrackingInfectious Disease and Outbreaks

Related entities

Zoonotic diseaseChina